Nicholas Brady, PhD — Assistant Professor of Pathology and Laboratory Medicine — Scholars @ Weill Cornell Medicine

ScholarsBetaWeill Cornell Medicine

Highlights

1
Nature communications · 2021
NBNicholas Brady RSRicha Singh HPHubert Pakula FKFrancesca Khani+7 more →DSDavid S. Rickman
PMID: 34099734PMCID: PMC8185096DOIFirst author73 citations

Publications

33

Funding

2 View NIH portfolio on RePORTER ↗

Active

1 grant

PI
Targeting drivers of tumor heterogeneity to block the progression to neuroendocrine prostate cancer
National Cancer Institute · 2024–2027Career
K22CA269707-03

Completed grants (1)

PI
Lineage plasticity as a mechanism of therapy resistance in prostate cancer
American Cancer Society · 2021–2023
PF-20-119-01-TBE

News mentions

1 View all WCM news ↗

Research Suggests How Tumors Evolve to Become Aggressive Form of Prostate Cancer
July 1, 2021
The genetic changes that underlie an especially lethal type of prostate cancer have been revealed in a new study by investigators at Weill Cornell Medicine. Learning more about what causes this type of cancer, called neuroendocrine prostate cancer (NEPC), could lead to new approaches for treating it.

External relationships

Professional Services

American Cancer Society